Strides Pharma Science announced that its 50:50 JV Strides Vivimed Pte., Singapore has received approval for Albendazole Tablets USP 200 mg from the United States Food & Drug Administration (US FDA). This is thesecond generic approval by US FDA for Albendazole Tablets.
Albendazole Tablets is a generic version of Albenza Tablets® of Amneal Pharmaceuticals, Inc. According to IQVIA MAT data, the US market for Albendazole Tablets USP 200 mg is approximately US$ 100 Mn.
0 thoughts on “Strides Vivimed JV receives USFDA approval for Albendazole Tablets”